Groin PainNCT05273008
Adductor Strength in Roller Hockey Athletes
An observational study of Groin Pain, run by University of Oviedo at 1 site in Spain.
Trial summary
Roller hockey athletes will be recruited along the season and will be examined for adductor strength and other potential groin pain risk factors. Read more about this study
- Who is it for?
- Ages 16 to 35 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Groin Pain
- How many people
- 251 participants
- Where
- 1 siteSpain
- Study dates
- 16 Sep 2021to 21 Jul 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 35 years
- Men only
- Healthy volunteers accepted
- Child, Adult
Study population: Athletes playing in the spanish roller hockey´s third division
Who may be able to join
- Participate in the roller hockey bronze division from spain
Who cannot join
- Deny participation
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Risk Factors for the Development of Groin Pain in Roller Hockey Athletes
Roller hockey athletes will be recruited along the season and will be examined for adductor strength and other potential groin pain risk factors.
Read the detailed description
Roller hockey athletes will be recruited and assess through the season. The assessment consist of an adductor, abductor strength measurement, Hip and Groin Outcome Score (HAGOS) completion and will be screened for other risk factors which are believed to cause groin pain (Age, previous injury)
- Conditions
- Groin Pain
- Keywords
- Roller hockey, Groin Pain, Risk factors
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Active hockey players | Observational study on 180 Hockey players |
What is being measured
The primary outcome is the main question the study is designed to answer.
Adductor Strength
Adductor strength will be measured with a dynamometer
Measured: November 2021-March 2022
Abductor strength
Abductor strength will be measured with a dynamometer
Measured: November 2021-March 2022
Adductor to abductor ratio
Ratio between adductor and abductor strength will be calculated
Measured: November 2021-March 2022
Secondary outcomes (2)
Hip and Groin Outcome Score
a questionnaire will be given to every participant to obtain information on groin pain symptoms in the last week
Measured: November 2021-March 2022
5 seconds squeeze test
While measuring adductor and abductor strength, pain will be assess during the test
Measured: November 2021-March 2022
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Mar 2022
- Study start16 Sep 2021
- Primary completion30 Jun 2022
- Study completion21 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Groin PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 251 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Oviedo
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hugo Olmedillas Fernandez, University of Oviedo
- Investigators
- Hugo Olmedillas, PhD, Principal investigator, Universidad de Oviedo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05273008
- Sponsor's protocol ID
- UO2021-03
- Status last verified
- Oct 2022
- First submitted
- 28 Feb 2022
- Last updated
- 1 Nov 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Risk Factors for the Development of Groin Pain in Roller Hockey Athletes
- ClinicalTrials.gov ID
- NCT05273008
- Acronym / sponsor ID
- UO2021-03
- Conditions
- Groin Pain
- Keywords
- Roller hockey, Groin Pain, Risk factors
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 251 participants (actual)
- Lead sponsor
- University of OviedoUniversity, hospital or other
- Study start
- 16 Sep 2021 (actual)
- Primary completion
- 30 Jun 2022 (actual)
- Study completion
- 21 Jul 2022 (actual)
- First posted
- 10 Mar 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Roller hockey athletes will be recruited along the season and will be examined for adductor strength and other potential groin pain risk factors.
Detailed description
Roller hockey athletes will be recruited and assess through the season. The assessment consist of an adductor, abductor strength measurement, Hip and Groin Outcome Score (HAGOS) completion and will be screened for other risk factors which are believed to cause groin pain (Age, previous injury)
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Active hockey players | – | –Observational study on 180 Hockey players |
Who may qualify
- Ages
- 16 to 35 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Athletes playing in the spanish roller hockey´s third division
Key inclusion criteria (1 listed)
- Participate in the roller hockey bronze division from spain
Key exclusion criteria (1 listed)
- Deny participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Adductor Strength
Time frame: November 2021-March 2022
Adductor strength will be measured with a dynamometer
Abductor strength
Time frame: November 2021-March 2022
Abductor strength will be measured with a dynamometer
Adductor to abductor ratio
Time frame: November 2021-March 2022
Ratio between adductor and abductor strength will be calculated
2 secondary outcomes
Hip and Groin Outcome Score
Time frame: November 2021-March 2022
5 seconds squeeze test
Time frame: November 2021-March 2022
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Nov 2022.
- Characterising groin pain in rink hockey: Function and five-second squeeze in Spanish playersLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Groin Pain
Recruiting
Comparing Two Laparoscopic Techniques for Hernia Repair in Children
Inguinal Hernia
Not yet recruiting
Lumbar ESP Block Versus TAP Block for Postoperative Pain Control in Children Undergoing Open Inguinal Hernia Repair
Inguinal Hernia, Postoperative Pain
Enrolling by invitation
An Exercise-based Rehabilitation Program for a Recreational Long-distance Runner With Long-standing Groin Pain
Groin Pain
Active, not recruiting
Urinary Catheterization Versus No Catheterization in Laparoscopic Total Extraperitoneal Inguinal Hernia Repair
Inguinal Hernias
Recruiting
Effect of Anterior Iliac Block on Postoperative Analgesia and Patient Satisfaction in Inguinal Hernia Repair Surgery
Anterior Ilıac Block, Hernia Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hugo Olmedillas, PhD principal investigator
Universidad de Oviedo
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Groin Pain, run by University of Oviedo at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adductor Strength (time frame: November 2021-March 2022). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2022.